Prognostic Impact of CA 19-9 on Outcome after Neoadjuvant Chemoradiation in Patients with Locally Advanced Pancreatic Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Impact of CA 19-9 on Outcome after Neoadjuvant Chemoradiation in Patients with Locally Advanced Pancreatic Cancer
Authors
Keywords
Pancreatic Cancer, Clinical Target Volume, Carbohydrate Antigen, Gross Tumor Volume, Radiation Therapy Oncology Group
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 21, Issue 8, Pages 2801-2807
Publisher
Springer Nature
Online
2014-06-11
DOI
10.1245/s10434-014-3607-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
- (2013) Brian A. Boone et al. JOURNAL OF SURGICAL ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome after neoadjuvant chemoradiation and correlation with nutritional status in patients with locally advanced pancreatic cancer
- (2013) P. Naumann et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Intensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer
- (2013) S.E. Combs et al. STRAHLENTHERAPIE UND ONKOLOGIE
- The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer
- (2013) Thierry Conroy et al. Current Oncology Reports
- Re-resection for Isolated Local Recurrence of Pancreatic Cancer is Feasible, Safe, and Associated with Encouraging Survival
- (2012) Oliver Strobel et al. ANNALS OF SURGICAL ONCOLOGY
- Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
- (2012) Sébastien Gaujoux et al. ANNALS OF SURGICAL ONCOLOGY
- Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis
- (2012) Falk Roeder et al. BMC CANCER
- Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
- (2012) Todd M. Bauer et al. CANCER
- Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 ≤90 U/mL and Comparison to the CONKO-001 Trial
- (2012) Adam C. Berger et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concurrent Full-Dose Gemcitabine: Analysis of a Prospective Phase 1/2 Dose Escalation Study
- (2012) Jeffrey M. Vainshtein et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Nutritional counselling and oral nutritional supplements in head and neck cancer patients undergoing chemoradiotherapy
- (2012) V. Valentini et al. JOURNAL OF HUMAN NUTRITION AND DIETETICS
- Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
- (2012) Daniel Habermehl et al. Radiation Oncology
- Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection
- (2012) D. Habermehl et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer
- (2012) Thomas Pausch et al. SURGERY
- Resection after neoadjuvant therapy for locally advanced, “unresectable” pancreatic cancer
- (2012) Oliver Strobel et al. SURGERY
- Nutritional surveillance and weight loss in head and neck cancer patients
- (2011) Ylva Tiblom Ehrsson et al. SUPPORTIVE CARE IN CANCER
- Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
- (2010) Naru Kondo et al. ANNALS OF SURGICAL ONCOLOGY
- Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse
- (2010) Emilie Thivat et al. BMC CANCER
- Impact of Obesity on Perioperative Outcomes and Survival Following Pancreaticoduodenectomy for Pancreatic Cancer: A Large Single-Institution Study
- (2010) Susan Tsai et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
- (2010) Sonja Gillen et al. PLOS MEDICINE
- A Systematic Review of Resectability and Survival After Concurrent Chemoradiation in Primarily Unresectable Pancreatic Cancer
- (2009) Alessio G. Morganti et al. ANNALS OF SURGICAL ONCOLOGY
- Influence of Obesity on Cancer-Related Outcomes After Pancreatectomy to Treat Pancreatic Adenocarcinoma
- (2009) Jason B. Fleming ARCHIVES OF SURGERY
- The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma
- (2009) J. Skipworth et al. DISEASES OF THE ESOPHAGUS
- The Impact of Resection Margin Status and Postoperative CA19-9 Levels on Survival and Patterns of Recurrence After Postoperative High-Dose Radiotherapy With 5-FU—Based Concurrent Chemotherapy for Resectable Pancreatic Cancer
- (2008) Timothy J. Kinsella et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Most Pancreatic Cancer Resections are R1 Resections
- (2008) Irene Esposito et al. ANNALS OF SURGICAL ONCOLOGY
- Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Gauri R. Varadhachary et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
- (2008) Douglas B. Evans et al. JOURNAL OF CLINICAL ONCOLOGY
- Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704
- (2008) Adam C. Berger et al. JOURNAL OF CLINICAL ONCOLOGY
- Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer
- (2008) Jeannine Bachmann et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Impact of Obesity on Perioperative Morbidity and Mortality after Pancreaticoduodenectomy
- (2008) Timothy K. Williams et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Intra-operative radiotherapy (IORT) in pancreatic cancer: Joint analysis of the ISIORT-Europe experience
- (2008) Vincenzo Valentini et al. RADIOTHERAPY AND ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now